A

Agilent Technologies Inc Price

Closed
A
$114.96
+$0.94(+0.82%)

*Data last updated: 2026-05-25 05:25 (UTC+8)

As of 2026-05-25 05:25, Agilent Technologies Inc (A) is priced at $114.96, with a total market cap of $32.48B, a P/E ratio of 31.78, and a dividend yield of 0.65%. Today, the stock price fluctuated between $113.05 and $116.40. The current price is 1.68% above the day's low and 1.23% below the day's high, with a trading volume of 1.66M. Over the past 52 weeks, A has traded between $111.06 to $116.40, and the current price is -1.23% away from the 52-week high.

A Key Stats

Yesterday's Close$114.79
Market Cap$32.48B
Volume1.66M
P/E Ratio31.78
Dividend Yield (TTM)0.65%
Dividend Amount$0.25
Diluted EPS (TTM)4.55
Net Income (FY)$1.30B
Revenue (FY)$6.94B
Earnings Date2026-05-27
EPS Estimate1.40
Revenue Estimate$1.79B
Shares Outstanding283.02M
Beta (1Y)1.219
Ex-Dividend Date2026-06-30
Dividend Payment Date2026-07-22

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOPadraig McDonnell
HeadquartersSanta Clara,CA,US
Official Websitehttps://www.agilent.com
Employees (FY)18.10K
Average Revenue (1Y)$383.86K
Net Income per Employee$71.98K

Learn More about Agilent Technologies Inc (A)

Agilent Technologies Inc (A) FAQ

What's the stock price of Agilent Technologies Inc (A) today?

x
Agilent Technologies Inc (A) is currently trading at $114.96, with a 24h change of +0.82%. The 52-week trading range is $111.06–$116.40.

What are the 52-week high and low prices for Agilent Technologies Inc (A)?

x

What is the price-to-earnings (P/E) ratio of Agilent Technologies Inc (A)? What does it indicate?

x

What is the market cap of Agilent Technologies Inc (A)?

x

What is the most recent quarterly earnings per share (EPS) for Agilent Technologies Inc (A)?

x

Should you buy or sell Agilent Technologies Inc (A) now?

x

What factors can affect the stock price of Agilent Technologies Inc (A)?

x

How to buy Agilent Technologies Inc (A) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Agilent Technologies Inc (A) Latest News

2026-05-25 05:13XRPL Developer Warns of Scams Targeting Xaman Wallet Users on May 25According to BlockBeats, XRPL developer Wietse Wind issued a security warning on May 25, alerting the XRP community to a rise in scams targeting Xaman Wallet users. Fraudsters are promoting fake desktop wallet applications and fabricated airdrop campaigns to trick users into connecting their wallets or downloading malicious software, which could result in asset theft. Wind advised users not to connect wallets to suspicious websites and to avoid downloading any unofficial applications to protect their funds.2026-05-25 05:08Tianji Intelligent Raises 1 Billion Yuan in Series B/B+ Round, Reaching Near 100 Billion ValuationOn May 25, Guangdong-based Tianji Intelligent announced the completion of 1 billion yuan in Series B and B+ funding rounds, achieving a post-money valuation of approximately 100 billion yuan and becoming a unicorn. The round was co-led by Hillhouse Capital and Meituan Strategic Investment, with participation from Tencent, Gaorong Capital, Lightmatching Capital, and GGV Capital. Proceeds will be allocated toward technology research and development, large-scale manufacturing ramp-up, and global sales network expansion.2026-05-25 05:01Hong Kong's Digital Asset Regulation Ahead of Europe, Says Financial Secretary ChenAccording to Hong Kong Financial Secretary Chen Mao-bo, in his latest statement, Hong Kong's digital asset development and regulatory approach have advanced further than Europe, positioning the city as a leader in blockchain governance. Chen noted that leveraging blockchain and artificial intelligence technology is an inevitable trend for future financial development, while acknowledging challenges such as money laundering and terrorist financing risks exploited through regulatory arbitrage across borders. He highlighted significant opportunities for cooperation and mutual learning between Hong Kong and European regulators to promote healthy industry development and contribute to global governance.2026-05-25 04:32Trader Closing Short Position and Liquidating 443,180 HYPE, Facing Over $2.5M Unrealized LossAccording to on-chain analytics platform Lookonchain, a trader who opened a short position in HYPE before the token's price surge is currently closing out and liquidating holdings. The address has unstaked 443,180 HYPE tokens worth approximately $27 million, of which 231,899 HYPE (worth $14.15 million) have already been sold. The remaining 211,281 HYPE tokens (worth $13 million) remain under liquidation. The trader still holds a short position of 141,500 HYPE worth approximately $8.67 million, with unrealized losses exceeding $2.5 million.2026-05-25 04:31Kalshi Launches Prediction Market Lobbying Group, Appoints Trump Official as Strategic AdvisorAccording to Odaily and Cointelegraph, prediction market platform Kalshi announced support for establishing Americans for Fair Markets, a new lobbying organization, and appointed Taylor Budowich, former deputy White House chief of staff under the Trump administration, as strategic advisor. The organization will advocate for federal-level prediction market regulations and counter what it describes as false narratives promoted by sports betting and casino industries. On the same day, the U.S. House of Representatives launched an investigation into Kalshi and its rival Polymarket, focusing on how the platforms handle insider trading issues. Kalshi said it supports regulation by the U.S. Commodity Futures Trading Commission and backs key safeguards including know-your-customer requirements and insider trading prohibitions.

Hot Posts About Agilent Technologies Inc (A)